USE OF BROMOCRIPTINE IN HYPERPROLACTINAEMIC ANOVULATION AND RELATED DISORDERSFRANKS S.1979; DRUGS; CHE; DA. 1979; VOL. 17; NO 5; PP. 337-348; BIBL. 2 P.Article

PREPARATION AND PROPERTIES OF TERTIARY P-ALKYLARYLPHOSPHINES CONTAINING STRAIGHT-CHAIN ALKYL GROUPSFRANKS S; HARTLEY FR.1980; PERKIN TRANS. 1; ISSN 0300-922X; GBR; DA. 1980; NO 10; PP. 2233-2237; BIBL. 24 REF.Article

Polycystic ovary syndrome in adolescentsFRANKS, S.International journal of obesity. 2008, Vol 32, Num 7, pp 1035-1041, issn 0307-0565, 7 p.Article

Parametric properties of numeral phrases in SlavicFRANKS, S.Natural language and linguistic theory. 1994, Vol 12, Num 4, pp 597-674, issn 0167-806XArticle

The ubiquitous polycystic ovaryFRANKS, S.Journal of endocrinology. 1991, Vol 129, Num 3, pp 317-319, issn 0022-0795, 3 p.Article

Polycystic ovary syndrome: a changing perspectiveFRANKS, S.Clinical endocrinology (Oxford. Print). 1989, Vol 31, Num 1, pp 87-120, issn 0300-0664Article

Is there a Pro-drop Parameter for Slavic? in Papers from the Eighteenth Regional Meeting, Chicago Linguistic Society, April 15-16, 1982, ed. by Kevin Tuite, Robinson Schneider, Robert ChametskyFRANKS, S.Papers from the... Regional Meeting. Chicago Ling. Soc. Chicago, Ill. 1982, Vol 18, pp 140-154Article

The Monosyllabic Head EffectFRANKS, S.Natural language and linguistic theory. 1989, Vol 7, Num 4, pp 551-563, issn 0167-806XArticle

Regulation of prolactin secretion by oestrogens: physiological and pathological significanceFRANKS, S.Clinical science (1979). 1983, Vol 65, Num 5, pp 457-462, issn 0143-5221Article

BASAL AND STIMULATED PROLACTIN LEVELS IN CHILDHOOD.FRANKS S; BROOK CGD.1976; HORMONE RES.; SWITZ.; DA. 1976; VOL. 7; NO 2; PP. 65-76; BIBL. 17 REF.Article

A copy and delete analysis of second position cliticsFRANKS, S.Zeitschrift für Slawistik. 1999, Vol 44, Num 2, pp 155-166, issn 0044-3506Article

The treatment of patients with polycystic ovaries undergoing IVF : Controversies in reproductive medicineFRANKS, S.Journal of assisted reproduction and genetics. 1997, Vol 14, Num 1, pp 12-14, issn 1058-0468Article

Medical progress : polycystic ovary syndromeFRANKS, S.The New England journal of medicine. 1995, Vol 333, Num 13, pp 853-861, issn 0028-4793Article

COMPLEXES OF LONG ALKYL CHAIN TERTIARY PHOSPHINES. I: THE PREPARATION AND CHARACTERISATION OF PLATINUM METAL COMPLEXES OF LONG-CHAIN TERTIARY PHOSPHINE LIGANDSFRANKS S; HARTLEY FR.1981; INORG. CHIM. ACTA; ISSN 0020-1693; ITA; DA. 1981; VOL. 47; NO 2; PP. 235-248; BIBL. 35 REF.Article

STEROID RESPONSIVENESS IN PHAEOCHROMOCYTOMADAGGETT P; FRANKS S.1977; BRIT. MED. J.; G.B.; DA. 1977; NO 6053; PP. 84; BIBL. 5 REF.Article

COMPARATIVE PHARMACOLOGY OF OESTROGENS AND CATECHOL OESTROGENS: ACTIONS ON THE IMMATURE RAT UTERUS IN VIVO AND IN VITROFRANKS S; MACLUSKY NJ; NAFTOLIN F et al.1982; J. ENDOCRINOL.; ISSN 0022-0795; GBR; DA. 1982; VOL. 94; NO 1; PP. 91-98; BIBL. 22 REF.Article

PREGNANCY AND LACTATION AFTER PITUITARY SURGERY.FRANKS S; KIWI R; NABARRO JDN et al.1977; BRIT. MED. J.; G.B.; DA. 1977; NO 6065; PP. 882; BIBL. 5 REF.Article

THE MASS SPECTRA OF SOME PARA SUBSTITUTED TRIARYLPHOSPHINES AND TRIARYLPHOSPHINE OXIDESMARSHALL G; FRANKS S; HARTLEY FR et al.1981; ORG. MASS SPECTROM.; ISSN 0030-493X; GBR; DA. 1981; VOL. 16; NO 6; PP. 272-274; BIBL. 5 REF.Article

THE PREPARATION AND PROPERTIES OF TERTIARY PHOSPHINES AND TERTIARY PHOSPHINE OXIDES WITH LONG ALKYL CHAINSFRANKS S; HARTLEY FR; MCCAFFREY DJA et al.1979; J. CHEM. SOC., PERKIN TRANS., 1; GBR; DA. 1979; NO 12; PP. 3029-3033; BIBL. 24 REF.Article

COMPLEXES OF LONG ALKYL CHAIN TERTIARY PHOSPHINES. IV: OXIDATIVE ADDITION OF METHYL IODIDE TO TRANS-(RHCL(CO)(PR₃)₂)FRANKS S; HARTLEY FR; CHIPPERFIELD JR et al.1981; INORG. CHEM.; ISSN 0020-1669; USA; DA. 1981; VOL. 20; NO 10; PP. 3238-3242; BIBL. 16 REF.Article

PREVALENCE AND PRESENTATION OF HYPERPROLACTINAEMIA IN PATIENTS WITH FUNCTIONLESS PITUITARY TUMOURS.FRANKS S; NABARRO JD; JACOBS HS et al.1977; LANCET; G.B.; DA. 1977; NO 8015; PP. 778-780; BIBL. 17 REF.Article

EFFECTIVENESS OF PERGOLIDE MESYLATE IN LONG TERM TREATMENT OF HYPERPROLACTINAEMIAFRANKS S; HORROCKS PM; LYNCH SS et al.1983; BRITISH MEDICAL JOURNAL; ISSN 0007-1447; GBR; DA. 1983; VOL. 286; NO 6372; PP. 1177-1179; BIBL. 10 REF.Article

FACTORS DETERMINING THE DIURNAL VARIATION IN PROGESTERONE-INDUCED GONADOTROPIN RELEASE IN THE OVARIECTOMIZED RATFRANKS S; MCELHONE J; YOUNG SN et al.1980; ENDOCRINOLOGY; USA; DA. 1980; VOL. 107; NO 1; PP. 353-358; BIBL. 36 REF.Article

POST-"PILL" AMENORRHOEA. CAUSE OR COINCIDENCE.JACOBS HS; KNUTH UA; HULL MGR et al.1977; BRIT. MED. J.; G.B.; DA. 1977; NO 6092; PP. 940-942; BIBL. 25 REF.Article

TREATMENT OF HYPERPROLACTINAEMIA WITH PERGOLIDE MESYLATE: ACUTE EFFECTS AND PRELIMINARY EVALUATION OF LONG-TERM TREATMENTFRANKS S; LYNCH SS; HORROCKS PM et al.1981; LANCET (BR. ED.); ISSN 0140-6736; GBR; DA. 1981; NO 8248; PP. 659-661; BIBL. 5 REF.Article